Skip to content

Ceva CEVA Gain on sale of business and assets

Gain on sale of business and assets at other companies

Oneok logo
OneokOKE
$0-100%
CVS Health logo
CVS HealthCVS
$0+100%
Cigna logo
CignaCI
$11M-73.2%
Ecolab logo
EcolabECL
-$1.1M-101%
PayPal Holdings, Inc. logo
PayPal Holdings, Inc.PYPL
$0
EMCOR Group logo
EMCOR GroupEME
$36.22M

Other financials

Income statement

See full
Revenue$27.0M+11.5%
Gross profit$23.3M+12.2%
Operating income-$5.1M-16.0%
Net income-$4.5M-34.0%
EPS (diluted)-$0.21-200%

Balance sheet

See full
Cash & equivalents$21.4M+13.6%
Total debt$16.9M+249%
Total equity$338.2M+25.7%
Total assets$388.2M+25.2%

Cash flow

See full
Operating cash flow-$4.9M+34.0%
CapEx$2.3M+644%
Free cash flow-$7.2M+6.7%

Valuation

See full
Market cap$1.25B+148%
Enterprise value$1.25B+154%
P/S11.2×+6.5×

Profitability

See full
Gross margin89.9%
Operating margin-0.3%
Net margin-10.5%+26.2pp
FCF margin1%

Returns & leverage

See full
Return on equity-3.9%+4.7pp
Debt / equity0.0×
Current ratio10.3×+2.8×

Where this comes from

Reported directly by Ceva in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: Ceva’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ceva's gain on sale of business and assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ceva's gain on sale of business and assets?
Ceva (CEVA) reported gain on sale of business and assets of -$0 in Q4 2025.
What is the long-term trend for Ceva's gain on sale of business and assets?
Over 2 years (2023 to 2025), Ceva's gain on sale of business and assets has grown at a -100.0% compound annual growth rate (CAGR), from $11.56M to $0.